Drug Type Small molecule drug |
Synonyms LC-51-0255, LC51 0255 |
Target |
Action modulators |
Mechanism S1PR1 modulators(Sphingosine 1-phosphate receptor Edg-1 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC28H31Cl2N3O3 |
InChIKeyXKKXISSRVOVRGI-UHFFFAOYSA-N |
CAS Registry1623066-63-6 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colitis, Ulcerative | Phase 2 | - | 01 Apr 2020 |





